About this trial
The goal of this study is to determine the extent to which excess dietary sugars serve as a precipitating factor in glucose intolerance in adults with cystic fibrosis (CF), a population at especially high risk for a unique form of diabetes (CF-related diabetes, CFRD) and with standard-of-care dietary recommendations (high-calorie, high-fat) that conflict with recommendations for other forms of diabetes.
This trial will investigate if the typical high-sugar, high-fat CF diet plays a role in diabetes risk and visceral fat accumulation in people with CF. A total of 30 participants will get a low-added sugar, high-fat diet and the other 30 will get a standard CF diet with no sugar restrictions. Participants will be randomized to the diet group they are assigned. All foods will be provided for 8 weeks.
Eligibility criteria
Qualifiers
Confirmed CF diagnosis
Ages 18 years and older
Baseline estimated daily total added sugar intake >16 tsp, as estimated from the Dietary Screener Questionnaire (DSQ).
Disqualifiers
Nocturnal tube feeds
BMI <18.5 kg/m2
Life expectancy < 12 months
Confirmed diagnosis of CFRD
Trial design
Treatments tested in this trial
- Low-added sugar, high-fat diet
- High-added sugar, high-fat CF diet
Treatment groups
Sponsors and collaborators
Emory University
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator